NASDAQ:AMTX Aemetis (AMTX) Stock Forecast, Price & News $4.19 -0.09 (-2.10%) (As of 10:04 AM ET) Add Compare Share Share Today's Range$4.19▼$4.5650-Day Range$4.28▼$8.2252-Week Range$1.16▼$8.99Volume65,359 shsAverage Volume822,151 shsMarket Capitalization$162.78 millionP/E RatioN/ADividend YieldN/APrice Target$13.42 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Aemetis MarketRank™ ForecastAnalyst RatingHold2.40 Rating ScoreUpside/Downside220.2% Upside$13.42 Price TargetShort InterestBearish12.07% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.35Based on 5 Articles This WeekInsider TradingSelling Shares$84,750 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.79) to ($0.57) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.77 out of 5 starsOils/Energy Sector204th out of 237 stocksIndustrial Organic Chemicals Industry14th out of 17 stocks 3.2 Analyst's Opinion Consensus RatingAemetis has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 3 buy ratings, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $13.42, Aemetis has a forecasted upside of 220.2% from its current price of $4.19.Amount of Analyst CoverageAemetis has only been the subject of 3 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted12.07% of the outstanding shares of Aemetis have been sold short.Short Interest Ratio / Days to CoverAemetis has a short interest ratio ("days to cover") of 6.4.Change versus previous monthShort interest in Aemetis has recently increased by 20.26%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldAemetis does not currently pay a dividend.Dividend GrowthAemetis does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AMTX. Previous Next 2.4 News and Social Media Coverage News SentimentAemetis has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Oils/Energy companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Aemetis this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for AMTX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows4 people have added Aemetis to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aemetis insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $84,750.00 in company stock.Percentage Held by Insiders14.34% of the stock of Aemetis is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 27.95% of the stock of Aemetis is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aemetis are expected to grow in the coming year, from ($1.79) to ($0.57) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aemetis is -1.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aemetis is -1.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Aemetis (NASDAQ:AMTX) StockAemetis, Inc. operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. In addition, it produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. Further, the company markets and supplies high-grade alcohol and hand sanitizer. Additionally, it researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. Furthermore, it sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.Read More AMTX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMTX Stock News HeadlinesSeptember 18, 2023 | americanbankingnews.comAemetis' (AMTX) Buy Rating Reiterated at HC WainwrightSeptember 17, 2023 | americanbankingnews.comAemetis, Inc. (NASDAQ:AMTX) Short Interest Up 20.3% in AugustSeptember 22, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.September 17, 2023 | americanbankingnews.comAemetis (NASDAQ:AMTX) Receives Buy Rating from HC WainwrightSeptember 15, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Its Buy Rating for Aemetis (AMTX)September 15, 2023 | markets.businessinsider.comWhat 5 Analyst Ratings Have To Say About AemetisSeptember 14, 2023 | finance.yahoo.comInsider Sell: Director Naomi Boness Sells 15,000 Shares of Aemetis IncSeptember 13, 2023 | msn.comAemetis gets key permit for California SAF, renewable diesel plantSeptember 22, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.September 12, 2023 | finance.yahoo.comBestGrowthStocks.com Issues an Extensive Comprehensive Analysis on Aemetis Inc.September 12, 2023 | americanbankingnews.comAemetis Target of Unusually Large Options Trading (NASDAQ:AMTX)September 6, 2023 | finance.yahoo.comAemetis Completes Expansion of India Biodiesel Plant One Year Ahead of Schedule, Increases Annual Production Capacity to 60 Million GallonsAugust 31, 2023 | msn.comAemetis (AMTX) Price Target Increased by 14.87% to 12.39August 29, 2023 | markets.businessinsider.comAemetis (AMTX) Receives a Hold from Truist FinancialAugust 26, 2023 | finance.yahoo.comAemetis (NASDAQ:AMTX) shareholders have earned a 32% CAGR over the last five yearsAugust 25, 2023 | msn.comAemetis makes first commercial sale of D3 RINs generated by dairy RNG projectAugust 25, 2023 | finance.yahoo.comAemetis Biogas Builds Revenues With First Commercial Sale of D3 RINs Generated by Dairy Renewable Natural Gas ProjectAugust 18, 2023 | money.usnews.comAemetis IncAugust 16, 2023 | markets.businessinsider.com4 Analysts Have This to Say About AemetisAugust 16, 2023 | msn.comUBS Upgrades Aemetis (AMTX)August 8, 2023 | finance.yahoo.comStonegate Capital Partners Updates Coverage On Aemetis, Inc. (AMTX) Q2 2023August 5, 2023 | msn.comAemetis GAAP EPS of -$0.68 misses by $0.30, revenue of $45.1M misses by $14.53MAugust 4, 2023 | markets.businessinsider.comAnalysts Offer Insights on NA Companies: Aemetis (AMTX), Conocophillips (COP) and Targa Resources (TRGP)August 3, 2023 | markets.businessinsider.comTruist Financial Remains a Hold on Aemetis (AMTX)August 3, 2023 | finance.yahoo.comAemetis Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comAemetis (AMTX) Reports Q2 Loss, Misses Revenue EstimatesJuly 31, 2023 | msn.comAemetis closes $25M USDA-guaranteed financing for biogas projectSee More Headlines Receive AMTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aemetis and its competitors with MarketBeat's FREE daily newsletter. Email Address AMTX Company Calendar Last Earnings8/03/2023Today9/22/2023Next Earnings (Estimated)11/02/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Industrial organic chemicals Sub-IndustryN/A SectorOils/Energy Current SymbolNASDAQ:AMTX CUSIPN/A CIK738214 Webwww.aemetis.com Phone(408) 213-0940Fax408-252-8044Employees167Year FoundedN/APrice Target and Rating Average Stock Price Forecast$13.42 High Stock Price Forecast$28.00 Low Stock Price Forecast$2.50 Forecasted Upside/Downside+220.2%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($4.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-107,760,000.00 Net Margins-77.46% Pretax Margin-74.85% Return on EquityN/A Return on Assets-43.45% Debt Debt-to-Equity RatioN/A Current Ratio0.19 Quick Ratio0.12 Sales & Book Value Annual Sales$256.51 million Price / Sales0.63 Cash FlowN/A Price / Cash FlowN/A Book Value($5.76) per share Price / Book-0.73Miscellaneous Outstanding Shares38,850,000Free Float33,279,000Market Cap$162.78 million OptionableNot Optionable Beta1.38 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Eric A. McAfee (Age 60)Co-Founder, Exec. Chairman & CEO Comp: $460kMr. Todd A. Waltz (Age 62)Exec. VP & CFO Comp: $371kMr. Andrew B. Foster (Age 58)Exec. VP & COO Comp: $361.94kMr. Sanjeev Gupta (Age 63)Exec. VP of Aemetis International Comp: $376.25kMr. J. Michael RockettExec. VP, Gen. Counsel & Corp. Sec.Key CompetitorsOrigin MaterialsNASDAQ:ORGNVerde Clean FuelsNASDAQ:VGASCENAQ EnergyNASDAQ:CENQFutureFuelNYSE:FFGevoNASDAQ:GEVOView All CompetitorsInsiders & InstitutionsNaomi Louise BonessSold 15,000 sharesTotal: $84,750.00 ($5.65/share)Chapin Davis Inc.Bought 8,623 shares on 8/30/2023Ownership: 0.051%Wolverine Trading LLCBought 18,000 shares on 8/23/2023Ownership: 0.000%Wells Fargo & Company MNSold 6,715 shares on 8/15/2023Ownership: 0.048%Point72 Asset Management L.P.Bought 3,401 shares on 8/15/2023Ownership: 0.009%View All Insider TransactionsView All Institutional Transactions AMTX Stock - Frequently Asked Questions Should I buy or sell Aemetis stock right now? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aemetis in the last twelve months. There are currently 1 sell rating, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AMTX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMTX, but not buy additional shares or sell existing shares. View AMTX analyst ratings or view top-rated stocks. What is Aemetis' stock price forecast for 2023? 5 Wall Street research analysts have issued 12-month target prices for Aemetis' stock. Their AMTX share price forecasts range from $2.50 to $28.00. On average, they expect the company's share price to reach $13.42 in the next year. This suggests a possible upside of 220.2% from the stock's current price. View analysts price targets for AMTX or view top-rated stocks among Wall Street analysts. How have AMTX shares performed in 2023? Aemetis' stock was trading at $3.96 at the start of the year. Since then, AMTX shares have increased by 5.8% and is now trading at $4.19. View the best growth stocks for 2023 here. Are investors shorting Aemetis? Aemetis saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 4,690,000 shares, an increase of 20.3% from the August 15th total of 3,900,000 shares. Based on an average daily trading volume, of 734,700 shares, the days-to-cover ratio is currently 6.4 days. View Aemetis' Short Interest. When is Aemetis' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our AMTX earnings forecast. How were Aemetis' earnings last quarter? Aemetis, Inc. (NASDAQ:AMTX) issued its quarterly earnings results on Thursday, August, 3rd. The specialty chemicals company reported ($0.68) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by $0.40. The specialty chemicals company earned $45.11 million during the quarter, compared to the consensus estimate of $67.30 million. What ETF holds Aemetis' stock ? Invesco Dorsey Wright Energy Momentum ETF holds 189,235 shares of AMTX stock, representing 1.60% of its portfolio. What other stocks do shareholders of Aemetis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include Pennsylvania Real Estate Investment Trust (PEI), Zosano Pharma (ZSAN), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Tilly's (TLYS), Auxly Cannabis Group (CBWTF), Novan (NOVN), Aeterna Zentaris (AEZS), American Cannabis (AMMJ) and Bionano Genomics (BNGO). What is Aemetis' stock symbol? Aemetis trades on the NASDAQ under the ticker symbol "AMTX." Who are Aemetis' major shareholders? Aemetis' stock is owned by many different institutional and retail investors. Top institutional investors include Encompass Capital Advisors LLC (4.65%), BlackRock Inc. (1.44%), Stifel Financial Corp (1.13%), Geode Capital Management LLC (0.80%), Citadel Advisors LLC (0.00%) and State Street Corp (0.35%). Insiders that own company stock include Andrew B Foster, Andrew B Foster, Francis P Barton, Francis P Barton, John R Block, John R Block, Naomi Louise Boness, Sanjeev Gupta, Timothy Alan Simon and Todd Waltz. View institutional ownership trends. How do I buy shares of Aemetis? Shares of AMTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Aemetis' stock price today? One share of AMTX stock can currently be purchased for approximately $4.19. How much money does Aemetis make? Aemetis (NASDAQ:AMTX) has a market capitalization of $162.78 million and generates $256.51 million in revenue each year. The specialty chemicals company earns $-107,760,000.00 in net income (profit) each year or ($4.05) on an earnings per share basis. How many employees does Aemetis have? The company employs 167 workers across the globe. How can I contact Aemetis? Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The official website for the company is www.aemetis.com. The specialty chemicals company can be reached via phone at (408) 213-0940, via email at investors@aemetis.com, or via fax at 408-252-8044. This page (NASDAQ:AMTX) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aemetis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.